CancerDR: Cancer drug resistance database

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Kumar, Rahul ^a   Chaudhary, Kumardeep ^a   Gupta, Sudheer ^a   Singh, Harinder ^a   Kumar, Shailesh ^a   Gautam, Ankur ^a   Kapoor, Pallavi ^a   Raghava, Gajendra P S ^a  

^a INSTITUTE OF MICROBIAL TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TUMOR PROTEIN;

ARTICLE; CHEMISTRY; COMPUTER INTERFACE; DRUG RESISTANCE; FACTUAL DATABASE; GENETICS; HUMAN; INTERNET; METABOLISM; MUTATION; NEOPLASM; PROTEIN TERTIARY STRUCTURE;

ANTINEOPLASTIC AGENTS; DATABASES, FACTUAL; DRUG RESISTANCE, NEOPLASM; HUMANS; INTERNET; MUTATION; NEOPLASM PROTEINS; NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; USER-COMPUTER INTERFACE;

EID: 84875176019     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01445     Document Type: Article

References (31)

1. Curtis, C. et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486, 346-52 (2012).
2. Gronbaek, K.,Hother, C. & Jones, P. A. Epigenetic changes in cancer. APMIS 115, 1039-59 (2007). (Pubitemid 350179474)
3. Sadikovic, B., Al-Romaih, K., Squire, J. A. & Zielenska, M. Cause and consequences of genetic and epigenetic alterations in human cancer. Curr Genomics 9, 394-408 (2008).
4. Wang, H. et al. Identification of the MEK1(F129L) activating mutation as a potential mechanism of acquired resistance to MEK inhibition in human cancers carrying the B-RafV600E mutation. Cancer Res 71, 5535-45 (2011).
5. Zdanowicz, M. M. The pharmacology of HIV drug resistance. Am J Pharm Educ 70, 100 (2006).
6. Bock, C. & Lengauer, T. Managing drug resistance in cancer: lessons from HIV therapy. Nat Rev Cancer 12, 494-501 (2012).
7. Chin, L., Andersen, J. N. & Futreal, P. A. Cancer genomics: from discovery science to personalized medicine. Nat Med 17, 297-303 (2011).
8. Jain, K. K. Role of nanobiotechnology in developing personalized medicine for cancer. Technol Cancer Res Treat 4, 645-50 (2005). (Pubitemid 43083348)
9. Mok, T. S. Personalized medicine in lung cancer: what we need to know. Nat Rev Clin Oncol 8, 661-8 (2011).
10. Tursz, T., Andre, F., Lazar, V., Lacroix, L. & Soria, J. C. Implications of personalized medicine-perspective from a cancer center. Nat Rev Clin Oncol 8, 177-83 (2011).
11. Rhee, S. Y. et al. Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res 31, 298-303 (2003).
12. Gifford, R. J. et al. The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance. Bioinformatics 25, 1197-8 (2009).
13. Tang, M. W., Liu, T. F. & Shafer, R. W. The HIVdb system for HIV-1 genotypic resistance interpretation. Intervirology 55, 98-101 (2012).
14. Garnett, M. J. et al. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 483, 570-5 (2012).
15. Barretina, J. et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603-7 (2012).
16. Bolton E., W. Y., Thiessen P.A. & Bryant S.H. PubChem: Integrated Platform of Small Molecules and Biological Activities. Annual Reports in Computational Chemistry Volume 4 (2008).
17. Chen, X., Ji, Z. L. & Chen, Y. Z. TTD: Therapeutic Target Database. Nucleic Acids Res 30, 412-5 (2002). (Pubitemid 34679600)
18. J Chem Base was used for structure searching and chemical database access and management. J Chem(5.10) (2012).
19. Remmert, M., Biegert, A., Hauser, A. & Soding, J. HHblits: lightning-fast iterative protein sequence searching by HMM-HMM alignment. Nat Methods 9, 173-5 (2012).
20. Kabsch, W. & Sander, C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22, 2577-637 (1983).
21. Eswar, N. et al. Comparative protein structure modeling using Modeller. Curr Protoc Bioinformatics Chapter 5, Unit 5 6 (2006).
22. Konagurthu, A. S., Whisstock, J. C., Stuckey, P. J. & Lesk, A. M. MUSTANG: a multiple structural alignment algorithm. Proteins 64, 559-74 (2006). (Pubitemid 44100724)
23. Laskowski, R. A., MacArthur, M. W., Moss, D. S., Thornton, J. M. PROCHECK: aprogram to check the stereochemical quality of protein structures. J Appl Cryst 26, 283-291 (1993).
24. Kaur, H.,Garg, A.&Raghava, G. P. PEPstr: a de novo method for tertiary structure prediction of small bioactive peptides. Protein Pept Lett 14, 626-31 (2007). (Pubitemid 47416366)
25. Thompson, J. D., Higgins, D. G. & Gibson, T. J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22, 4673-80 (1994). (Pubitemid 24354800)
26. Troshin, P. V., Procter, J. B. & Barton, G. J. Java bioinformatics analysis web services for multiple sequence alignment-JABAWS:MSA. Bioinformatics 27, 2001-2 (2011).
27. Li, H. &Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-60 (2009).
28. Li, H. et al. The Sequence Alignment/Map format and SAM tools. Bioinformatics 25, 2078-9 (2009).
29. Milne, I. et al. Tablet-next generation sequence assembly visualization. Bioinformatics 26, 401-2 (2010).
30. Stanke, M., Steinkamp, R.,Waack, S.&Morgenstern, B.AUGUSTUS: a web server for gene finding in eukaryotes. Nucleic Acids Res 32, W309-12 (2004). (Pubitemid 38997349)
31. Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J Mol Biol 215, 403-10 (1990).